Search Results | Inflammatory Bowel Diseases | Oxford Academic

Skip to Main Content

1-9 of 9

Save search

Sort by

Sort Order Select

Journal Article

REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS IN THE UNITED STATES OF AMERICA

PDF

Sabree Burbage and others

Inflammatory Bowel Diseases, Volume 30, Issue Supplement_1, February 2024, Pages S86–S87, https://doi.org/10.1093/ibd/izae020.189

Published: 25 January 2024

Journal Article

GUT-BIOME MODULATION WITH HUMAN MILK OLIGOSACCHARIDE (HMO) BASED SYNBIOTIC FOR A COMPLETE AND DEEP REMISSION IN CROHN’S DISEASE: A CASE STUDY

PDF

Sai Tummala and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S78–S79, https://doi.org/10.1093/ibd/izac247.151

Published: 26 January 2023

Journal Article

PATTERNS OF STEROID USE AMONG A REAL-WORLD NATIONAL COHORT OF VETERANS WITH INFLAMMATORY BOWEL DISEASE

PDF

Codey Pham and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S79–S80, https://doi.org/10.1093/ibd/izac247.152

Published: 26 January 2023

Journal Article

EFFICIENCY OF DUAL THERAPY WITH VEDOLIZUMAB AND TOFACITINIB IN REFRACTORY ULCERATIVE COLITIS PATIENTS – SINGLE CENTRE EXPERIENCE

PDF

Martin Kolar and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S78, https://doi.org/10.1093/ibd/izac247.150

Published: 26 January 2023

Journal Article

A PHASE II OPEN LABEL STUDY OF NEIHULIZUMAB, AN ANTI-CD162 (PSGL-1) ANTIBODY, IN PATIENTS WITH MODERATE TO SEVERE ACTIVE, ANTI-TNFα AND/OR ANTI-INTEGRIN REFRACTORY ULCERATIVE COLITIS

PDF

David Rubin and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S77–S78, https://doi.org/10.1093/ibd/izac247.149

Published: 26 January 2023

Journal Article

REAL-WORLD EXPERIENCE WITH TOFACITINIB DOSE DE-ESCALATION IN PATIENTS WITH MODERATE AND SEVERE ULCERATIVE COLITIS

PDF

Amy Yu and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S80, https://doi.org/10.1093/ibd/izac247.153

Published: 26 January 2023

Journal Article

VEDOLIZUMAB, USTEKINUMAB AND TOFACITINIB AS TRIPLE THERAPY FOR ULCERATIVE COLITIS

PDF

Theresa Thurston and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S81–S82, https://doi.org/10.1093/ibd/izac247.156

Published: 26 January 2023

Journal Article

USE OF UPADACITINIB IN 11 TOFACITINIB-REFRACTORY ULCERATIVE COLITIS PATIENTS AT A SINGLE TERTIARY CARE CENTER

PDF

Jake Levine and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S81, https://doi.org/10.1093/ibd/izac247.155

Published: 26 January 2023

Journal Article

THE EFFECT OF VEDOLIZUMAB ON CD8 T CELL REPERTOIRE HOMOGENEITY AND BLOOD-GUT TRAFFICKING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

PDF

Kyle Williams and others

Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S80–S81, https://doi.org/10.1093/ibd/izac247.154

Published: 26 January 2023